Maderazo, Jonathan .
HRN: 22-05-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFUROXIME 1.5GM (VIAL)
10/02/2022
10/09/2022
IV
1.5 G
Q 8 H
Mild TBI Secondary To MVA Non Collisiona
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes